{ "cik": 1295947, "cik_padded": "0001295947", "entityName": "Prestige Consumer Healthcare Inc.", "fiscal_years": [ { "accn": "0001295947-26-000016", "filed": "2026-05-14", "fiscal_year": 2026, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 156283000.0, "capex": 11178000.0, "cash": 63868000.0, "cost_of_revenue": 493127000.0, "eps_diluted": 3.91, "free_cash_flow": 246449000.0, "gross_profit": 595578000.0, "net_income": 190301000.0, "operating_cash_flow": 257627000.0, "operating_income": 309409000.0, "revenue": 1088705000.0, "stockholders_equity": 1887516000.0, "total_assets": 3494313000.0, "total_liabilities": 1606797000.0 }, "period_end": "2026-03-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5470517725187264, "leverage": 0.8512759626938262, "net_margin": 0.17479574356689828, "operating_margin": 0.2841991172999114, "revenue_growth_yoy": -0.043117101819185384, "roa_avg2y": 0.0551874558383048, "roa_period_end": 0.054460204337733915, "roe_avg2y": 0.10224604309086606, "roe_period_end": 0.10082086721384083 } }, { "accn": "0001295947-26-000016", "filed": "2026-05-14", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 51509000.0, "capex": 8224000.0, "cash": 97884000.0, "cost_of_revenue": 503299000.0, "eps_diluted": 4.29, "free_cash_flow": 243291000.0, "gross_profit": 634463000.0, "net_income": 214605000.0, "operating_cash_flow": 251515000.0, "operating_income": 336775000.0, "revenue": 1137762000.0, "stockholders_equity": 1834897000.0, "total_assets": 3402218000.0, "total_liabilities": 1567321000.0 }, "period_end": "2025-03-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5576412290092304, "leverage": 0.854173831010678, "net_margin": 0.18862029141419734, "operating_margin": 0.2959977570001459, "revenue_growth_yoy": 0.01102316864781576, "roa_avg2y": 0.0638645008990966, "roa_period_end": 0.06307796854875261, "roe_avg2y": 0.12298347756047956, "roe_period_end": 0.11695751859641168 } }, { "accn": "0001295947-26-000016", "filed": "2026-05-14", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 25000000.0, "capex": 9550000.0, "cash": 46469000.0, "cost_of_revenue": 500909000.0, "eps_diluted": 4.17, "free_cash_flow": 239376000.0, "gross_profit": 624448000.0, "net_income": 209339000.0, "operating_cash_flow": 248926000.0, "operating_income": 342429000.0, "revenue": 1125357000.0, "stockholders_equity": 1655084000.0, "total_assets": 3318417000.0, "total_liabilities": 1663333000.0 }, "period_end": "2024-03-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5548888041750307, "leverage": 1.0049840370639798, "net_margin": 0.1860200807388233, "operating_margin": 0.30428477363183415, "revenue_growth_yoy": -0.0020998027001263605, "roa_avg2y": 0.06275012567171043, "roa_period_end": 0.06308399456728916, "roe_avg2y": 0.13496303230514917, "roe_period_end": 0.1264824021016456 } }, { "accn": "0001295947-26-000016", "filed": "2026-05-14", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 50000000.0, "capex": 7784000.0, "cash": 58489000.0, "cost_of_revenue": 502431000.0, "eps_diluted": -1.65, "free_cash_flow": 221932000.0, "gross_profit": 625294000.0, "net_income": -82306000.0, "operating_cash_flow": 229716000.0, "operating_income": -22415000.0, "revenue": 1127725000.0, "stockholders_equity": 1447084000.0, "total_assets": 3353729000.0, "total_liabilities": 1906645000.0 }, "period_end": "2023-03-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5544738300560864, "leverage": 1.3175772795497704, "net_margin": -0.0729841051674832, "operating_margin": -0.01987629962978563, "revenue_growth_yoy": 0.03764496527458291, "roa_avg2y": -0.023434281313306028, "roa_period_end": -0.02454163708516699, "roe_avg2y": -0.05442267732779669, "roe_period_end": -0.05687714051153907 } }, { "accn": "0001295947-25-000017", "filed": "2025-05-09", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 9642000.0, "cash": 27185000.0, "cost_of_revenue": 466166000.0, "eps_diluted": 4.04, "free_cash_flow": 250280000.0, "gross_profit": 620646000.0, "net_income": 205381000.0, "operating_cash_flow": 259922000.0, "operating_income": 329919000.0, "revenue": 1086812000.0, "stockholders_equity": 1577611000.0, "total_assets": 3670681000.0, "total_liabilities": 2093070000.0 }, "period_end": "2022-03-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5710702495003736, "leverage": 1.3267339033513332, "net_margin": 0.188975646201919, "operating_margin": 0.30356584211436755, "revenue_growth_yoy": 0.1520588531480392, "roa_avg2y": 0.05785417764678475, "roa_period_end": 0.05595174301444337, "roe_avg2y": 0.13990964978819168, "roe_period_end": 0.1301848174233065 } }, { "accn": "0001295947-24-000017", "filed": "2024-05-15", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 11867000.0, "capex": 22243000.0, "cash": 32302000.0, "cost_of_revenue": 395893000.0, "eps_diluted": 3.25, "free_cash_flow": 213364000.0, "gross_profit": 547472000.0, "net_income": 164682000.0, "operating_cash_flow": 235607000.0, "operating_income": 297402000.0, "revenue": 943365000.0, "stockholders_equity": 1358298000.0, "total_assets": 3429273000.0, "total_liabilities": 2070975000.0 }, "period_end": "2021-03-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5803395292384178, "leverage": 1.524683832266557, "net_margin": 0.17456869822391125, "operating_margin": 0.31525655499197025, "revenue_growth_yoy": -0.0203995804820303, "roa_avg2y": 0.04743706700303521, "roa_period_end": 0.0480224234116094, "roe_avg2y": 0.13022102433548982, "roe_period_end": 0.12124143597354925 } }, { "accn": "0001295947-23-000017", "filed": "2023-05-05", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 56721000.0, "capex": 14560000.0, "cash": 94760000.0, "cost_of_revenue": 410787000.0, "eps_diluted": 2.78, "free_cash_flow": 202564000.0, "gross_profit": 552223000.0, "net_income": 142281000.0, "operating_cash_flow": 217124000.0, "operating_income": 291155000.0, "revenue": 963010000.0, "stockholders_equity": 1170971000.0, "total_assets": 3513905000.0, "total_liabilities": 2342934000.0 }, "period_end": "2020-03-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5734343360920447, "leverage": 2.000847160177323, "net_margin": 0.14774612932368303, "operating_margin": 0.30233850115782807, "revenue_growth_yoy": -0.013083932086941997, "roa_avg2y": 0.040915084685837017, "roa_period_end": 0.04049084992337584, "roe_avg2y": 0.1255345636716396, "roe_period_end": 0.12150685200572858 } }, { "accn": "0001295947-22-000015", "filed": "2022-05-06", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 49978000.0, "capex": 10480000.0, "cash": 27530000.0, "cost_of_revenue": 420201000.0, "eps_diluted": -0.69, "free_cash_flow": 178804000.0, "gross_profit": 555576000.0, "net_income": -35800000.0, "operating_cash_flow": 189284000.0, "operating_income": 67503000.0, "revenue": 975777000.0, "stockholders_equity": 1095831000.0, "total_assets": 3441036000.0, "total_liabilities": 2345205000.0 }, "period_end": "2019-03-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5693677961255492, "leverage": 2.1401155835160712, "net_margin": -0.03668871063777892, "operating_margin": 0.06917871603860308, "revenue_growth_yoy": -0.06281532762378035, "roa_avg2y": -0.00994216879247639, "roa_period_end": -0.010403843493645516, "roe_avg2y": -0.031480262622771926, "roe_period_end": -0.03266927108285858 } }, { "accn": "0001295947-21-000021", "filed": "2021-05-07", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 12532000.0, "cash": 32548000.0, "cost_of_revenue": 464674000.0, "eps_diluted": 6.34, "free_cash_flow": 197578000.0, "gross_profit": 576505000.0, "net_income": 339570000.0, "operating_cash_flow": 210110000.0, "operating_income": 215474000.0, "revenue": 1041179000.0, "stockholders_equity": 1178610000.0, "total_assets": 3760612000.0, "total_liabilities": 2582002000.0 }, "period_end": "2018-03-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5537040220749746, "leverage": 2.190717879536064, "net_margin": 0.3261398856488654, "operating_margin": 0.20695192661396358, "revenue_growth_yoy": 0.18039475772623179, "roa_avg2y": 0.08852235934493924, "roa_period_end": 0.09029647302088066, "roe_avg2y": 0.3393733331534376, "roe_period_end": 0.28811057092676967 } }, { "accn": "0001295947-20-000018", "filed": "2020-05-08", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 2977000.0, "cash": 41855000.0, "cost_of_revenue": 381774000.0, "eps_diluted": 1.3, "free_cash_flow": 145695000.0, "gross_profit": 500286000.0, "net_income": 69395000.0, "operating_cash_flow": 148672000.0, "operating_income": 205643000.0, "revenue": 882060000.0, "stockholders_equity": 822549000.0, "total_assets": 3911348000.0, "total_liabilities": 3088799000.0 }, "period_end": "2017-03-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5671791034623495, "leverage": 3.7551550120418358, "net_margin": 0.07867378636373942, "operating_margin": 0.23313946897036483, "roa_period_end": 0.017741965174154793, "roe_period_end": 0.08436579462135387 } } ], "latest_filing": { "accn": "0001295947-26-000016", "filed": "2026-05-14", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001295947.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001295947.json" }, "ticker": "PBH" }